Atossa Therapeutics Inc (ATOS)
1.69
+0.01
(+0.60%)
USD |
NASDAQ |
May 09, 16:00
1.685
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Cash from Operations (TTM): -20.94M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.94M |
| September 30, 2023 | -19.89M |
| June 30, 2023 | -21.42M |
| March 31, 2023 | -22.90M |
| December 31, 2022 | -20.76M |
| September 30, 2022 | -19.90M |
| June 30, 2022 | -17.55M |
| March 31, 2022 | -16.94M |
| December 31, 2021 | -16.47M |
| September 30, 2021 | -16.24M |
| June 30, 2021 | -15.86M |
| March 31, 2021 | -12.75M |
| December 31, 2020 | -11.57M |
| September 30, 2020 | -10.85M |
| June 30, 2020 | -9.937M |
| March 31, 2020 | -10.21M |
| December 31, 2019 | -9.128M |
| September 30, 2019 | -8.864M |
| June 30, 2019 | -9.393M |
| March 31, 2019 | -8.724M |
| December 31, 2018 | -8.962M |
| September 30, 2018 | -8.201M |
| June 30, 2018 | -7.604M |
| March 31, 2018 | -7.120M |
| December 31, 2017 | -6.594M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.267M |
| June 30, 2017 | -3.930M |
| March 31, 2017 | -4.241M |
| December 31, 2016 | -5.375M |
| September 30, 2016 | -7.972M |
| June 30, 2016 | -12.09M |
| March 31, 2016 | -13.95M |
| December 31, 2015 | -13.95M |
| September 30, 2015 | -12.72M |
| June 30, 2015 | -12.22M |
| March 31, 2015 | -10.95M |
| December 31, 2014 | -10.56M |
| September 30, 2014 | -10.48M |
| June 30, 2014 | -10.24M |
| March 31, 2014 | -10.10M |
| December 31, 2013 | -8.83M |
| September 30, 2013 | -8.114M |
| June 30, 2013 | -5.527M |
| March 31, 2013 | -4.230M |
| December 31, 2012 | -3.90M |
| September 30, 2012 | -3.006M |
| June 30, 2012 | -4.200M |
| March 31, 2012 | -4.491M |
| December 31, 2011 | -3.492M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-22.90M
Minimum
Mar 2023
-8.864M
Maximum
Sep 2019
-15.35M
Average
-16.24M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| AngioDynamics Inc | -17.20M |
| Achieve Life Sciences Inc | -24.48M |
| Biolase Inc | -14.09M |
| Outset Medical Inc | -131.37M |
| Perspective Therapeutics Inc | -36.91M |